Insights into antibody catalysis: Structure of an oxygenation catalyst at 1.9-Å resolution by Hsieh-Wilson, Linda C. et al.
Proc. Natl. Acad. Sci. USA
Vol. 93, pp. 5363-5367, May 1996
Biochemistry
Insights into antibody catalysis: Structure of an oxygenation
catalyst at 1.9-A resolution
(crystal structure/catalytic antibody/oxidation)
LINDA C. HSIEH-WILSON*t, PETER G. SCHULTZ*t§, AND RAYMOND C. STEVENSt§
*Howard Hughes Medical Institute and tDepartment of Chemistry, University of California, Berkeley, CA 94720
Contributed by Peter G. Schultz, January 24, 1996
ABSTRACT The x-ray crystal structures of the sulfide
oxidase antibody 28B4 and of antibody 28B4 complexed with
hapten have been solved at 2.2-A and 1.9-A resolution, respec-
tively. To our knowledge, these structures are the highest
resolution catalytic antibody structures to date and provide
insight into the molecular mechanism of this antibody-
catalyzed monooxygenation reaction. Specifically, the data
suggest that entropic restriction plays a fundamental role in
catalysis through the precise alignment of the thioether sub-
strate and oxidant. The antibody active site also stabilizes
developing charge on both sulfur and periodate in the tran-
sition state via cation-pi and electrostatic interactions, re-
spectively. In addition to demonstrating that the active site of
antibody 28B4 does indeed reflect the mechanistic informa-
tion programmed in the aminophosphonic acid hapten, these
high-resolution structures provide a basis for enhancing
turnover rates through mutagenesis and improved hapten
design.
Antibodies have been shown to catalyze a wide variety of
reactions with exquisite control over the reaction pathway (1).
However, the further improvement of antibody catalysis de-
pends on high-resolution structural data. The few reported
crystal structures of catalytic antibodies have focused, with one
exception, on esterolytic reactions (2-6). We now report the
three-dimensional structure of an antibody (28B4) that cata-
lyzes the monooxygenation of thioethers. An examination of
the structural data may provide insight into enhancing the
catalytic efficiencies of antibodies as well as elucidate the
mechanisms and evolution of enzymatic catalysis.
Antibody 28B4 catalyzes the periodate-dependent oxidation
(Fig. 1) of sulfide 1 to the corresponding sulfoxide 2 (7).
Similar oxygen transfer reactions are performed by naturally
occurring monooxygenase enzymes for the biosynthesis of
steroids and neurotransmitters, the degradation of endoge-
nous substances, and the detoxification of xenobiotics (8, 9).
This reaction was initially examined to extend antibody catal-
ysis to this important class of redox reactions and (ii) to expand
the range of "cofactors" used in biological catalysis. The
combination of highly abundant and versatile chemical re-
agents such as metal hydrides and Lewis acids together with
antibody catalysis might lead to a number of advantages over
natural enzymes, such as eliminating the need for expensive
cofactor recycling in large-scale enzymatic synthesis (10).
The periodate-dependent oxygenation of thioethers can
occur either via sulfur attack on the periodate oxygen in a
concerted, SN2-like transition state (TS*) or by initial addition
to the iodine center followed by oxygen transfer (Fig. 1).
Hammett o-p values, solvent isotope effects, and pH-
dependence studies (11, 12) support the former mechanism
but do not exclude initial attack on iodine. Antibody 28B4 was
raised against aminophosphonic acid hapten 3, which to a large
degree mimics the stereoelectronic features of both transition
states. Specifically, hapten 3 contains phosphonate and nitro-
phenyl moieties designed to provide two binding sites precisely
oriented for the periodate and nitroaryl sulfide substrates.
Moreover, the positively charged ammonium ion and dianionic
phosphonate group mimic the developing charges on sulfur
and the periodate oxygens, respectively, in the proposed
transition states.
Eight antibodies were found to catalyze the oxidation of
substrate 1 and related sulfides with a range of turnover
numbers and stereoselectivities. Antibody 28B4, which was
among the most efficient, binds hapten 3 with high affinity
(Kd= 52 nM) and catalyzes the periodate-dependent oxidation
of sulfide 1 with a kcat value of 8.2 s-1 (kcat/Km= 1.9 x 105
M-1s-1), similar to the flavin-dependent enzymes (7). To
determine the catalytic mechanism of 28B4 and the extent to
which the active site evolved in response to mechanistic
instructions from the hapten, the free and hapten-bound
structures of the antigen-binding fragment (Fab) of the murine
antibody 28B4 have been solved to 2.2-A and 1.9-A resolution,
respectively.
MATERIALS AND METHODS
Fab Preparation and Purification. Monoclonal antibody
28B4 was generated using standard protocols from BALB/c
mice immunized with hapten 3 conjugated to the carrier
protein keyhole-limpet hemocyanin. Large amounts of full-
length antibody were produced in ascites fluid and purified by
protein A affinity (Schleicher & Schuell Affinica) chromatog-
raphy. Fab was prepared using immobilized papain (Pierce)
and purified by size exclusion (Sephacryl S-200; Pharmacia)
and cation exchange (Mono-S column; Pharmacia) chroma-
tography.
Crystallization. Initial crystallization conditions were ob-
tained using the incomplete crystallization screen of Jancarik
and Kim (13). Crystals were grown at 4°C using the hanging-
drop procedure in wells containing 0.5 ml of 20% PEG 4K,
10% isopropanol, and 0.1 M Tris (pH 8.5). Drops consisting of
a 2-,ul aliquot of a protein solution with or without hapten (2
mM hapten and 12.5 mg Fab per ml in 10 mM Tris/100 mM
NaCl/1 mM methionine/0.5 mM EDTA, pH 8.5) were mixed
with 2 ,ul of the well solution. Plate-shaped crystals (up to 0.2
x 0.4 x 1.0 mm) belonged to space group P1 with unit-cell
dimensions a = 52.7 A, b = 58.2 A, c = 43.2 A, a = 94.3°,
X3 = 113.8°, and y = 78.90 (Fab-hapten) and a = 47.2 A, b =
58.6 A, c = 43.4 A, a = 95.30, 13 = 103.2, and y = 93.60 (free
Fab).
Data deposition: The atomic coordinates and structure factors have
been deposited in the Protein Data Bank, Chemistry Department,
Brookhaven National Laboratory, Upton, NY 11973 [references IKEL
(hapten-Fab), IKEM (apo-Fab), RlKELSF (hapten-Fab), and
R1KEMSF (apo-Fab)].
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Data Collection. Data sets were collected at - 165°C (Fab-
hapten) and 4°C (free Fab) using an R-AXIS II detector
system mounted on a Rigaku RU-200 x-ray generator (50 kV
and 100 mA). The reflections were indexed using DENZO 1.3.0
(written by Z. Otwinowski) and merged/scaled using the
programs ROTAVATA, AGROVATA, and TRUNCATE of the CCP4
suite (14). For the Fab-hapten cocrystals, a total of 83,241
observations were recorded for 31,750 unique reflections. The
reduced data set was 98% complete between 20 and 1.9 A
(63% between 1.9 and 1.7 A) with an Rmerge value of 0.058. The
data set for the uncomplexed Fab, which consisted of 51,820
observations and 21,852 unique reflections, was 98% complete
between 20 and 2.2 A (43% between 2.2 and 2.0 A) with an
Rmerge value of 0.078.
Structure Determination. The Fab-hapten structure was
solved by molecular replacement using the program package
AMORE (15) and data in the 15- to 3.0-A resolution range.
Coordinates from the ligf Fab constant domains (CL + CH1)
(16) and the AbM-minimized (17) antibody 28B4 variable
domains with deletions in the solvent-exposed loop regions
were used separately as models for the corresponding parts of
the complex. The height of the peak corresponding to the
solution was 5 times that of the next highest peak, and the
resultant model gave an R factor of 0.48. Alternate rounds of
model building with the molecular graphics program o (18)
and refinement of the atomic coordinates using X-PLOR version
3.1 (19) were performed until the solvent-exposed loops were
rebuilt and the minimization was complete. The final model
has an R factor of 19.9% (Rfree = 25.8) in the 6- to 1.9-A
resolution range. The averaged rms deviations are 0.012 A and
1.727 A for the bond lengths and angles, respectively.
The free Fab structure was solved similarly using the hapten-
Fab 28B4 structure as the search model. After model building
and refinement, the final R factor for the free Fab structure is
18.3% (Rfree = 28.8) in the 6- to 2.2-A resolution range, with
rms deviations of 0.012 A and 1.769° A for the bond lengths
and angles, respectively. The stereochemistries of the models
were verified with PROCHECK version 2.1.4 (20). The final Fab
and Fab-hapten complex structures contain 157 and 306
waters, respectively, and 435 amino acids. The amino acid
sequence of the 28B4 Fab has been reported elsewhere (21)
with the exception of the N-termini (DVL for the murine light
FIG. 1. The periodate (NaIO4)-depen-
dent oxygenation of sulfide 1 can occur via
two possible transition states to give sulfoxide
product 2. Hapten 3 mimics the stereoelec-
tronic features of both transition states and
was used to raise antibody 28B4.
chain and EVKLV for the murine heavy chain). Fab residue
numbering follows Kabat numbering (22) throughout.
RESULTS AND DISCUSSION
The hapten is bound in a cleft 10 A deep and 7 A wide with
the aromatic nitro group at the bottom and the phosphonic
acid, aliphatic linker, and carboxylic acid groups near the
surface of the cleft (Fig. 2). Approximately 212 A2 of the
hapten (68% of the total solvent-accessible surface) is buried
within the Fab. There are 11 van der Waals interactions and
FIG. 2. An Fo-Fc omit electron density map (contoured at 3.5 a-)
showing the hapten (red) in the antibody active site. The antibody
contacts the hapten (within 3.5 A) primarily through the CDR loops
Hi (H33 and H35), H2 (H50, H52, and H53), H3 (H95), Li (L32), and
L3 (L89).
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four hydrogen bonds between the hapten and the antibody,
with the majority of the hydrogen bonds and salt bridges
(TyrH33, ArgH52, and LysH53) contacting the three oxygens of
the tetrahedral phosphonate group (Fig. 3). Specifically, the
hydroxyl group of TyrH33 (2.5 A away), the guanidino group of
ArgH52 (2.8 A away), and possibly the amino group of LysH53
interact with each of the thtee oxygens in the tetrahedral
phosphonate group. The close proximity of the positively
charged guanidinium group of ArgH52 and the 6-amino group
of LysH53 should also produce large, favorable electrostatic
interactions with the dianionic phosphonate group. Interest-
ingly, recognition of the phosphonate moiety by 28B4 is very
similar to recognition of the phosphocholine phosphate group
by the McPC603 antibody (23). In fact, the two antibodies
share the same germ-line family ofVH region genes (22 and 24;
P. L. Yang, personal communication). That this conserved
phosphonate binding site acts as a periodate binding pocket is
consistent with kinetic analysis of 28B34, which shows a Michae-
lis constant (Km) of 252
-A for sodium periodate (7).
The structure' also conifirms earlier observations demon-
strating the specificity of antibody 28B4 for p-nitroaryl sub-
strates (7). (Antibody 28B4 does not catalyze oxygenation of
benzyl methyl sulfide.) The nitrophenyl ring of hapten 3 is
deeply embedded in a hydrophobic cavity (TrpH95, TyrH33,
TrpH47, PheL89, and PheH50) and sandwiched between the
aromatic rings of TrpH95 and PheH50 (-3.5 A away from the
hapten; Fig. 3). Specific recognition of the p-nitro group is
achieved through AsnH35, which is asymmetrically hydrogen-
bonded between the two oxygens of the buried nitro group (2.9
A and 3.5 A away from ND2). AsnH35 may be the sole
determinant of the selectivity for nitro-containing substrates.
Preliminary analysis of the Kabat database suggests that
AsnH35 corresponds to a somatic mutation in the affinity
maturation of 28B4 from the Vll germ-line gene (22; P. L.
Yang, personal communication). Good complementarity is
observed for the positively charged ammonium moiety, which
mimics the developing charge on sulfur in the TS*. A favorable
interaction occurs between the ammonium ion and the aro-
matic fr-system of TyrU32 (3.9 A from the benzylic carbon);
such "amino-aromatic" interactions have been previously
observed in McPC603 and other protein structures (25, 26).
The highly selective contacts to the nitroaryl moiety contrast
with the relatively nonspecific recognition of the aliphatic
linker functionality of hapten 3. The solvent accessibility of the
FIG. 3. Structure of the 28B4 active site showing the aminophosphonic acid hapten (yellow) and its solvent-accessible surface (yellow dots).
The aromatic nitro group is buried in a hydrophobic pocket, and the aliphatic linker and phosphonate moieties reside near the surface. The solvent
accessiblity of the linker may reflect the influence of the carrier protein upon hapten presentation. The Ca backbone is shown in blue and the side
chains of important residues in white (heteroatom colors: 0, red; N, blue; and P, pink).
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linker may reflect the influence of the carrier protein upon
hapten presentation. Studies probing the substrate specificity
of 28B4 are consistent with these observations and demon-
strate that the aliphatic substituent, in contrast to the nitroaryl
ring, can be replaced with a variety of other functional groups
(7). Indeed, the limited antibody complementarity to this
region may be responsible for the modest enantioselectivity of
28B4 (16% enantiomeric excess for chiral sulfoxide forma-
tion). These results reinforce the intuitive notion that more
rigid or immunogenic elements in the linker may improve
antibody-hapten complementarity, thus affording a more
enantioselective catalyst.
The overall data suggests that both entropic and enthalpic
factors contribute to catalysis. A network of hydrogen bonding,
electrostatic, and iT-stacking interactions lock the periodate
ion and nitroaryl substrate into a reactive orientation. Thus, a
large component of the antibody binding energy may function
as an "entropy trap" to freeze out rotational and translational
degrees of freedom in the TSt (27). In addition to aligning the
periodate cofactor, residues TyrH33, ArgH52, and LysH53 may
stabilize the developing negative charge on the periodate
oxygens in the TS*. The developing positive charge on sulfur
in the TS* may be stabilized by the electron-rich aromatic ring
of TyrL32 via a putative cation-pi interaction. Such interactions
have been invoked to explain cyclophane-catalyzed SN2 reac-
tions, acetylcholine recognition, and the ion selectivity of
channel proteins (26, 28, 29). The close van der Waals contact
between TyrL32 and the benzylic carbon of the hapten may also
explain the high rate of acceleration for p-nitrothioanisole
oxidation (7). The nonoverlapping binding sites for the perio-
date and thioether substrates, one at the surface and the other
buried, are consistent with the random-binding, sequential
kinetic mechanism observed (7).
In addition to identifying active site residues important for
catalysis, this study provides the first opportunity to compare
the bound and unbound forms of a catalytic antibody directly.
Such comparisons offer a glimpse into the mechanism of
antibody-substrate association and directly address the issue of
antibody-combining site flexibility (30-32). In this example,
small side chain and main chain rearrangements consistent
with the lock-and-key mechanism (33) occur upon hapten
binding (Fig. 4; rms main chain deviation for variable domains,
0.31 A). Notably, TyrH33 moves 0.6 closer to the haptenic
phosphonate oxygens, and the indole ring of TrpH95 stacks
("0.5 A) more closely with the nitroaryl ring. Moreover, the
side chain of LysH53, which has ill-defined electron density in
the unbound form, appears to be oriented toward the phos-
phonate moiety in the hapten-bound form. With the exception
of TyrL32, which undergoes a small main chain movement
toward the hapten (rms deviation, 0.45 A), the CDR loop Li
(primarily L28-35; rms deviation, 0.44-0.98 A) moves away
from the hapten, presumably to accommodate it. Molecular
dynamics simulations confirm the flexibility of the TyrL32 side
chain, which makes very few electrostatic and van der Waals
contacts with the rest of the protein. Dynamic conformational
changes of this sort are likely to play an important role in the
FIG. 4. Superposition of the hapten-Fab and free Fab structures. The hapten-bound structure is depicted in blue and the apo-Fab structure in
green.
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reorganization of antibody active sites into the Michaelis
complex and the optimum geometry for TSt stabilization.
The structure of the antibody-hapten complex identifies
specific mutations that may clarify the catalytic mechanism of
antibody 28B4 and improve its efficiency and stereoselectivity.
For example, mutation of TyrL32 to a phenylalanine or tryp-
tophan should provide insight into the importance of the
putative cation-pi interaction. Furthermore, the introduction of
negatively charged residues proximal to the haptenic ammo-
nium group (for example, SerL92 or AsnL28 to Glu) and
additional hydrogen bonds to the phosphonate moiety (PheH50
to Tyr) may enhance the catalytic activity of 28B4. It may be
possible to improve the enantioselectivity of 28B4 by optimiz-
ing the antibody-hapten shape complementarity around the
linker moiety (HisL27d to Trp; AsnL28 to Gln). In addition to
mutagenesis studies, new hapten designs replacing the ali-
phatic linker with more rigid or immunogenic functionalities to
restrict the mobility of the sulfur moiety may enhance the
stereoselectivity and efficiency of the elicited antibodies. Hap-
ten designs that improve ammonium ion recognition (linkage
to carrier protein via the aryl ring) or modulate the relative
positions of the thioether and periodate substrates (replace-
ment of the phosphonate moiety with an arsonate or sulfonate
group) may also increase turnover rates. Finally, sequence and
structural comparisons to other existing antibodies raised
against hapten 3 with varying sulfide oxidase activity and
stereoselectivity should dramatically increase our understand-
ing of the relationship between combining site geometry and
catalytic efficiency.
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